Clinical Trials Logo

Brain Injury clinical trials

View clinical trials related to Brain Injury.

Filter by:

NCT ID: NCT00817791 Completed - Brain Injury Clinical Trials

Preconditioning With Hyperbaric Oxygen in Cardiovascular Surgery

Start date: November 2007
Phase: N/A
Study type: Interventional

Animal studies have shown that preconditioning with hyperbaric oxygen can induce central nervous system and heart ischemic tolerance. This study was designed to determine the protective effect of hyperbaric oxygen preconditioning on brain and myocardium ischemia-reperfusion injury during coronary artery bypass graft surgery.

NCT ID: NCT00809055 Completed - Brain Injury Clinical Trials

MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine

Start date: November 2008
Phase: Phase 4
Study type: Interventional

Over the last 30 years the survival rates for babies born prematurely have improved greatly with research. As these babies grow up, we have found that many of the premature babies have learning and movement problems. The purpose of this research is to learn why premature infants are at risk for learning disabilities and movement problems later in childhood and whether this is changed by caffeine therapy. Caffeine is often used in premature babies to help them to breathe on their own. Nearly all babies born before 30 weeks gestation receive caffeine while they are in the neonatal intensive care unit (NICU). Scientists have shown that caffeine therapy given to premature babies reduces their disabilities. We will use brain monitoring, including electro-encephalogram (EEG) and magnetic resonance imaging (MRI) to understand how the brain of a premature baby develops and whether caffeine in high doses enhances protection of the developing brain. Just as we monitor the heart and lungs to improve our care of premature babies, we wish to monitor the brain so that we can understand how to improve our care for the brain.

NCT ID: NCT00797680 Completed - Cardiac Arrest Clinical Trials

Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest

Start date: October 2008
Phase: Phase 2
Study type: Interventional

In this study, children who survive cardiac arrest will be evaluated whether 24 or 72 hours of whole body hypothermia (cooling) during recovery is better to help prevent brain injury and improve outcome. The investigators will also test the safety of cooling patients for 24 and 72 hours. The investigators hypothesize that 72 hours of cooling will be more beneficial than 24 hours without compromising safety.

NCT ID: NCT00779324 Completed - Brain Injury Clinical Trials

Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study

Start date: August 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to study the effect of amantadine on irritability and aggression caused by traumatic brain injury.

NCT ID: NCT00761228 Suspended - Brain Injury Clinical Trials

Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury

NH001-2
Start date: July 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the drug apomorphine in subjects who are in a Vegetative State or a Minimally Conscious State.

NCT ID: NCT00746291 Terminated - Cerebral Palsy Clinical Trials

Heart Rate Variability (HRV) Among Children With Brain Damage

Start date: June 2008
Phase: N/A
Study type: Interventional

to investigate the function of the autonomic nervous system in children with with post traumatic brain injury and children with cerebral palsy through an analysis of heart rate variability (HRV) occurring with walking performance.

NCT ID: NCT00729261 Completed - Brain Injury Clinical Trials

A Prospective Trial of Elective Extubation in Brain Injured Patients.

Start date: August 2004
Phase: Phase 1
Study type: Interventional

Identifying the optimal time of extubation in a brain injured population should improve patient outcome. Brain injured patients usually remain intubated due to concerns of airway maintenance. Current practice argues that unconscious patients need to remain intubated to protect their airways. More recent data however suggests that delaying extubation in this population increases pneumonias and worsens patient outcomes. We designed a safety and feasibility study of randomizing brain injured patients into early or delayed extubation. The purpose was to gain insight into patient safety concerns and to obtain estimates of sample size needed for a larger study.

NCT ID: NCT00724594 Completed - Brain Injury Clinical Trials

Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)

Start date: August 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this trial was to find the best dose of N-acetylcysteine (NAC) to decrease brain injury in babies exposed to intrauterine infection without causing significant side effects.

NCT ID: NCT00715494 Completed - Muscle Weakness Clinical Trials

A Pilot Study of Rehabilitation Among Intensive Care Unit (ICU) Survivors: the RETURN Trial

RETURN
Start date: July 2008
Phase: N/A
Study type: Interventional

Intensive care unit (ICU) hospitalization saves lives but often does so at a high personal cost to ICU survivors who frequently experience significant cognitive impairment and an array of physical and functional disabilities that limit their recovery and quality of life. While the problems experienced by these patients are likely amenable to rehabilitation, few ICU survivors receive focused rehabilitation following hospital discharge. The purpose of this study is to initiate and test the feasibility of a complex intervention incorporating a cognitive, physical, and functional rehabilitation program at the time of hospital discharge and implement this 12 week program using in-home visits and tele-technology. We hypothesize that this interdisciplinary rehabilitation program, initiated at hospital discharge and implemented using in-home visits and tele-technology, will result in improved recovery of neuropsychological and physical performance and overall functional status.

NCT ID: NCT00649961 Completed - Premature Birth Clinical Trials

Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study

MIND
Start date: May 2010
Phase: Phase 2
Study type: Interventional

Preterm babies are at risk of brain injury. Melatonin, a naturally occurring hormone, may reduce this risk. The unborn baby receives melatonin from the mother but following premature delivery there maybe a period of prolonged melatonin deficiency. This deficiency may be harmful because studies suggest that melatonin is important in protecting the brain and reducing the risk of brain injury after preterm birth. The purpose of this study is to find the ideal dose of melatonin to give to preterm babies. We intend to study a total of 24 babies less than 31 weeks gestation and who are less than 7 days old.